APM Aptorum Group Ltd

CIK 0001734005 2 ready 8-Ks latest August 7, 2026, 4:00 PM ET RSS · JSON

Activity: ELEVATED 2 filings / 30d vs 0 baseline

Ready 8-Ks 2

Latest filing August 7, 2026, 4:00 PM ET

Top materiality 0.75

Event mix regulatory ×1 · m_and_a ×1

Sentiment 1 pos · 0 neg · 1 neu

SHENANIGAN SCORE 1 / 7 see the board

Recent 8-K filings for APM

Highest-materiality recent filing

Aptorum completes merger with DiamiR, redomiciles as Niki BioSolutions, trades under NIKI

July 20, 2026, 8:15 AM ET M&A materiality 0.75 neutral item 2.01 item 3.03 item 5.02 item 5.03 item 8.01 item 9.01

Merger closed July 20, 2026; Aptorum redomiciled to Delaware and renamed Niki BioSolutions, Inc.
DiamiR shareholders received ~1.98M shares of Niki common; Aptorum shareholders got ~814K common and ~180K Series A preferred.

August 7, 2026, 4:00 PM ET regulatory materiality 0.50 positive item 8.01

Niki BioSolutions regains Nasdaq minimum bid price compliance

Received Nasdaq deficiency letter on March 5, 2026 for bid price below $1.00 for 30 consecutive business days.
July 20, 2026, 8:15 AM ET M&A materiality 0.75 neutral item 2.01 item 3.03 item 5.02 item 5.03 item 8.01 item 9.01

Aptorum completes merger with DiamiR, redomiciles as Niki BioSolutions, trades under NIKI

Merger closed July 20, 2026; Aptorum redomiciled to Delaware and renamed Niki BioSolutions, Inc.

Max materiality 0.75 · Median 0.62 · Most common event regulatory

1 positive 0 negative 1 neutral